ABCB4 gene mutation-associated cholelithiasis in adults

Gastroenterology

Volumn 125, Issue 2, 2003, Pages 452-459

  Rosmorduc, Olivier ^a,b   Hermelin, Brigitte ^a,b   Boelle, Pierre Yves ^b   Parc, Rolland ^c   Taboury, Jacques ^d   Poupon, Raoul ^a,b,e  

^a ASSISTANCE PUBLIQUE HÔPITAUX DE PARIS   (France)

^b INSERM   (France)

^c SORBONNE UNIVERSITÉ   (France)

^d Centre de Radiologie   (France)

^e HÔPITAL SAINT ANTOINE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ABCB4 GENE; ADULT; AGE; ANAMNESIS; ARTICLE; CHOLELITHIASIS; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; GENE; GENE SEQUENCE; GENETIC ANALYSIS; GENETIC CODE; GENETIC RISK; HETEROZYGOSITY; HOMOZYGOSITY; HUMAN; MAJOR CLINICAL STUDY; MALE; PATHOGENESIS; PHENOTYPE; POINT MUTATION; PRIORITY JOURNAL; RECURRENT DISEASE; RISK; RISK FACTOR; SYMPTOM;

EID: 0041665024     PISSN: 00165085     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0016-5085(03)00898-9     Document Type: Article

References (36)

1. Puglielli L, Amigo L, Arrese M, Nunez L, Rigotti A, Garrido J, Gonzales S, Mingrone G, Greco A, Accatino L, Nervi F. Protective role of biliary cholesterol and phospholipid lamellae against bile acid-induced cell damage. Gastroenterology 1994;107:244-254.
2. Jacquemin E, De Vree M, Cresteil D, Sokal E, Sturm E, Dumont M, Scheffer G, Paul M, Burdelski M, Bosma P, Bernard O, Hadchouel M, Oude Elferink R. The wide spectrum of multidrug resistance 3 deficiency: from neonatal cholestasis to cirrhosis of adulthood. Gastroenterology 2001;120:1448-1458.
3. Dixon P, Weerasekera N, Linton K, Donaldson O, Chambers J, Egginton E, Weaver J, Nelson-Piercy C, Swiet M, Warnes G, Elias E, Higgins C, Johnston D, McCarthy M, Williamson C. Heterozygous MDR3 missense mutation associated with intrahepatic cholestasis of pregnancy: evidence for a defect in protein trafficking. Hum Mol Genet 2000;9:1209-1217.
4. Jacquemin E, Cresteil D, Manouvrier S, Boute O, Hadchouel M. Heterozygous non-sense mutation of the MDR3 gene in familial intrahepatic cholestasis of pregnancy. Lancet 1999;353:210-211.
5. Simon E, Marschall H-U, Glantz A, Rath W, Matern S, Lammert F. Mutations of hepatocanalicular ABC transporters in intrahepatic cholestasis of pregnancy (abstr). Hepatology 2002;36:335A.
6. Strautnieks S, Lopes A, Underhill J, Gerred S, Nibbering K, Knisely A, Portman B, Bomford A, Heaton N, Mieli-Vergani G, Oude Elferink R, O'Grady J, Wali S, Thompson R. Critical residues in the multidrug resistance 3 protein gene associated with adult onset of cholangiopathy and intrahepatic cholestasis of pregnancy (abstr). Hepatology 2002;36:415A.
7. Rosmorduc O, Hermelin B, Poupon R. MDR3 gene defect in adults with symptomatic intrahepatic and gallbladder cholesterol cholelithiasis. Gastroenterology 2001;120:1449-1467.
8. Fracchia M, Pellegrino S, Secreto P, Gallo L, Masoero G, Pera A, Galatola G. Biliary lipid composition in cholesterol microlithiasis. Gut 2001;48:702-706.
9. Shoda J, Oda K, Suzuki H, Sugiyama Y, Ito K, Cohen D, Feng L, Kamiya J, Nimura Y, Kano M, Matsuzaki Y, Tanaka N. Etiologic significance of defects in cholesterol, phospholipid, and bile acid metabolism in the liver of patients with intrahepatic calculi. Hepatology 2001;33:1194-1205.
10. Lafortune M, Gariepy G, Dumont A, Breton G, Lapointe R. The V-shaped artifact of the gallbladder wall. AJR Am J Roentgenol 1986;147:505-508.
11. Burnham K, Anderson D. Model selection and multi-model interference, New York: Springer-Verlag, 2002.
12. Ihaka R, Gentleman R. A language for data analysis and graphics. J Comput Graph Stat 1996;5:299-314.
13. Lincke CR, Smit JJ, van der Velde-Koerts T, Borst P. Structure of the human MDR3 gene and physical mapping of the human MDR locus. J Biol Chem 1991;266:5303-5310.
14. van der Bliek AM, Kooiman PM, Schneider C, Borst P. Sequence of mdr3 cDNA encoding a human P-glycoprotein. Gene 1988;71:401-411.
15. Attili A, De Santis A, Capri R, Repice A, Maselli S. The natural history of gallstones: the GREPCO experience. The GREPCO Group. Hepatology 1995;21:656-660.
16. Diehl AK. Symptoms of gallstone disease. Baillieres Clin Gastroenterol 1992;6:635-657.
17. Diehl AK, Schwesinger W, Holleman DJ, Chapman J, Kurtin W. Clinical correlates of gallstone composition: distinguishing pigment from cholesterol stones. Am J Gastroenterol 1995;90:967-972.
18. Diehl AK, Holleman DJ, Chapman J, Schwesinger W, Kurtin W. Gallstone size and risk of pancreatitis. Arch Intern Med 1997;157:1674-1678.
19. Tint GS, Dyrszka H, Sanghavi B, Patel G, Patel S, Shefer S, Salen G. Lithotripsy plus ursodiol is superior to ursodiol alone for cholesterol gallstones. Gastroenterology 1992;102:2042-2049.
20. Tomida S, Abei M, Yamaguchi T, Matsuzaki Y, Shoda J, Tanaka N, Osuga T. Long-term ursodeoxycholic acid therapy is associated with reduced risk of biliary pain and acute cholecystitis in patients with gallbladder stones: a cohort analysis. Hepatology 1999;30:6-13.
21. Shoda J, Kano M, Asano T, Irimura T, Ueda T, Iwasaki R, Furukawa M, Kamiya J, Nimura Y, Todoroki T, Matsuzaki Y, Tanaka N. Secretory low-molecular-weight phospholipases A2 and their specific receptor in bile ducts of patients with intrahepatic calculi: factors of chronic proliferative cholangitis. Hepatology 1999;29:1026-1036.
22. Soloway R, Weinman S. Oxidative stress as a cause of biliary lithiasis: new possibilities for medical therapy of stones or a false alarm. Hepatology 2000;32:670-671.
23. Hanna M, Brault M, Kwan T, Kast C, Gros P. Mutagenesis of transmembrane domain 11 of P-glycoprotein by alanine scanning. Biochemistry 1996;35:3625-3635.
24. Kwan T, Gros P. Mutational analysis of the P-glycoprotein first intracellular loop and flanking transmembrane domains. Biochemistry 1998;37:3337-3350.
25. Caseres J, Kornblihtt A. Alternative spicing: multiple control mechanisms and involvement in human disease. Trends Genet 2002;18:186-193.
26. Bouchard G, Nelson HM, Lammert F, Rowe LB, Carey MC, Paigen B. High-resolution maps of the murine chromosome 2 region containing the cholesterol gallstone locus, Lith1. Mamm Genome 1999;10:1070-1074.
27. Bouchard G, Carey M, Paigen B. In the genetic locus containing the second cholesterol gallstone gene Lith2, an Mrp2 polymorphism is linked to heightened secretion of organic anions (abstr). Gastroenterology 2000;118:A1017.
28. Khanuja B, Cheah YC, Hunt M, Nishina PM, Wang DQ, Chen HW, Billheimer JT, Carey MC, Paigen B. Lith1, a major gene affecting cholesterol gallstone formation among inbred strains of mice. Proc Natl Acad Sci U S A 1995;92:7729-7733.
29. Wang DQ, Lammert F, Paigen B, Carey MC. Phenotypic characterization of lith genes that determine susceptibility to cholesterol cholelithiasis in inbred mice. Pathophysiology of biliary lipid secretion. J Lipid Res 1999;40:2066-2079.
30. Fouassier L, Kinnman N, Lefévre G, Lasnier E, Rey C, Poupon R, Oude Elferink R, Housset C. Contribution of mrp2 in alteration of canalicular bile formation by the endothelin antagonist bosentan. J Hepatol 2002;37:184-191.
31. Glasinovic J, Valdievieso V, Covarrubias C, Marinovic I, Miquel J, Nervo F. Pregnancy and gallstones. In: Reyes H, Leuschner U, Arias I, eds. Pregnancy, sex hormones and the liver. Dordrecht, The Netherlands: Kluwer, 1996:267-281.
32. Lammert F, Marschall H-U, Glantz A, Matern S. Intrahepatic cholestasis of pregnancy: molecular pathogenesis, diagnosis and management. J Hepatol 2000;33:1012-1021.
33. Leevy C, Koneru B, Klein K. Recurrent familial prolonged intrahepatic cholestasis of pregnancy associated with chronic liver disease. Gastroenterology 1997;113:966-972.
34. Lammert F, Wang DQ, Paigen B, Carey MC. Spontaneous cholesterol gallstone formation on normal diet characterizes mice with disrupted Mdr2 P-glycoprotein gene and provides new insights into cholesterol crystalization and bile formation (abstr). Gastroenterology 1998;114:A527.
35. Oude Elferink R, Ottenhof R, van Wiijland M, Frijters C, van Nieuwkerk C, Groen A. Uncoupling of biliary phospholipid and cholesterol secretion in mice with reduced expression of mdr2 P-glycoprotein. J Lipid Res 1996;37:1065-1075.
36. Oude Elferink R, Groen A. Genetic defects in hepatobiliary transport. Biochim Biophys Acta 2002;1586:129-145.